Alto Neuroscience (NYSE:ANRO – Get Free Report)‘s stock had its “outperform” rating reiterated by investment analysts at William Blair in a research report issued on Wednesday, RTT News reports. Several other research firms also recently weighed in on ANRO. Robert W. Baird started coverage on shares of Alto Neuroscience in a research report on Tuesday, […]